Proteus syndrome

Proteus syndrome is an extremely rare, progressive, mosaic overgrowth disorder caused by a somatic activating variant in the oncogene AKT1 (c.49G>A, p.Glu17Lys), which constitutively activates the PI3K–AKT–mTOR signaling pathway.[1][2] The disorder produces disproportionate, asymmetric, and distorting postnatal overgrowth of tissues derived from all three germinal layers—most commonly bone, skin, connective tissue, adipose tissue, and vasculature.[2][3] Craniofacial hyperostosis involving the cranium, maxilla, mandible, and external auditory meatus is a frequent skeletal manifestation and is often the finding that brings affected individuals to the attention of oral and maxillofacial specialists.[4][5] The signature dental radiographic pattern is unilateral, progressive bony overgrowth of the jaws with associated dental anomalies. Management is multidisciplinary and symptom-directed; targeted pharmacologic inhibition of the AKT/mTOR pathway is under active investigation.[6][7]

• Current preferred name: Proteus syndrome (PS).
• Molecular designation: AKT1-related Proteus syndrome (AKT1-PS) when the somatic variant is confirmed.[8]
• AKT1-related overgrowth spectrum: Applied when a mosaic AKT1 variant is present but clinical criteria score 2–9 points, below the diagnostic threshold for PS.[8]
• Eponym origin: Named by Wiedemann et al. (1983) after Proteus, the shape-shifting sea god of Greek mythology, reflecting the extreme phenotypic variability.[3][9]
• Historical association: Joseph Carey Merrick ("The Elephant Man"), originally attributed to neurofibromatosis type 1, is now considered to have had Proteus syndrome.[3]
• Obsolete or misleading terms: "PTEN-related Proteus syndrome" is no longer accepted; individuals with PTEN variants and segmental overgrowth are reclassified under PTEN hamartoma tumor syndrome.[8][10]

• Incidence is estimated at fewer than 1 per 1,000,000 live births; only several hundred confirmed cases have been identified in the United States and Western Europe.[3][9]
• No sex predilection has been established.[2]
• Onset is characteristically postnatal: most affected individuals appear normal at birth, with overgrowth first becoming apparent between 6 and 18 months of age and progressing throughout childhood and adolescence.[9][10]
• Craniofacial hyperostosis involving the cranium, maxilla, mandible, and external auditory meatus frequently occurs; an NIH cohort study of 29 patients with cranial involvement found frontal or frontoparietal hyperostosis in the majority, with unilateral predominance.[4]
• Significant diagnostic over-reporting exists: a reassessment of 205 published cases found that only about half met consensus diagnostic criteria.[11][12]

General presentation

Proteus syndrome manifests as mosaic, sporadic, and progressive overgrowth.[2][8] Overgrowth is disproportionate and distorting—unlike the proportionate "ballooning" enlargement seen in hemihyperplasia syndromes, affected bones grow abnormally long and misshapen with thin cortices and deficient overlying soft tissue.[2][11]

Craniofacial and oral findings

• Hemifacial hypertrophy: Unilateral enlargement of the facial skeleton is a characteristic craniofacial manifestation, producing progressive facial asymmetry.[5][13]
• Gingival and oral mucosal overgrowth: Reported in approximately one-third of genetically confirmed patients.[14]
• Macroglossia: Unilateral tongue enlargement has been described on the affected side.[13]
• High-arched palate.[13]
• Dental anomalies: Accelerated dental development and premature eruption of teeth on the affected side, malpositioned teeth, unilateral enamel hypoplasia, and root dilaceration.[5][14][15]
• External auditory canal narrowing: Hyperostosis of the external auditory meatus is a highly specific finding.[2][3]

Systemic features

• Cerebriform connective tissue nevus (pathognomonic when present), typically on the plantar surface.[2][14]
• Epidermal nevi, capillary/venous/lymphatic vascular malformations, and dysregulated adipose tissue (lipomas and lipohypoplasia).[2][3]
• Deep venous thrombosis and pulmonary embolism are major causes of morbidity and mortality.[10][16]
• Specific tumors include meningiomas, ovarian cystadenomas, parotid monomorphic adenomas, and genitourinary neoplasms.[17][18]
• Mortality rate of approximately 25% before age 22.[9]

Location and distribution in the jaws

Craniofacial hyperostosis in Proteus syndrome characteristically involves the cranial vault, maxilla, mandible, and external auditory meatus in a mosaic, asymmetric pattern.[2][4] Jaw involvement is typically unilateral, corresponding to the affected side of the face.[5][19] The mandibular body and ramus on the involved side are commonly enlarged.[13][19]

Periphery and shape

• Bony overgrowth produces irregular, poorly defined hyperostotic margins rather than smooth cortical expansion.[2][20]
• Hyperplasia of osteoid with variable calcification creates abnormal bony edges that may be difficult to distinguish from normal bone radiographically.[2]
• Exostoses may project from the outer cortex of the calvarium or facial bones.[5]

Internal architecture

• Cranial hyperostosis consists primarily of diploic space expansion, particularly in the frontal and parietal bones.[4][21]
• Abnormally calcified connective tissue may be present within or adjacent to areas of bony overgrowth.[2]
• The overgrown bone may appear heterogeneous, with areas of variable mineralization reflecting the hamartomatous nature of the process.[2][22]

Effects on teeth and adjacent structures

• Accelerated dental development: Premature development and eruption of both primary and permanent teeth on the affected side is a characteristic finding on panoramic radiographs.[5][19]
• Asymmetric dental age: The dental age on the affected side may be markedly advanced compared with the contralateral side.[19]
• Root abnormalities: Pronounced idiopathic root resorption and root dilaceration of teeth on the involved side.[5][13]
• Enamel defects: Unilateral enamel hypoplasia restricted to the affected side has been reported.[14][15]
• Malpositioned teeth resulting from alveolar overgrowth.[13][15]
• Enlarged mandibular canal: Widening of the inferior alveolar canal on the affected side, reflecting enlargement of the inferior alveolar nerve.[5]
• Condylar overgrowth: Enlargement and deformity of the mandibular condyle with degenerative temporomandibular joint changes, which may be asymptomatic despite severe morphologic distortion.[13]

Extent and cortical involvement

• Cranial hyperostosis is predominantly unilateral, with frontal or frontoparietal involvement most common; occipital hyperostosis occurs occasionally.[4]
• Hyperostosis of the external auditory meatus, producing canal narrowing, is a highly specific radiographic finding included in the diagnostic criteria.[2][3]
• Cranial hyperostosis typically extends extracranially rather than causing intracranial compression, although rare compressive effects have been reported.[4]
• Invasion of joint spaces by abnormal bone, eventually resulting in joint immobility, is a recognized skeletal feature that may affect the temporomandibular joint.[2][13]

Growth pattern

• Overgrowth is relentlessly progressive, particularly during childhood and adolescence, and is disproportionate—bones grow abnormally in shape rather than simply enlarging proportionately.[2][11]
• Long bones in the extremities show overgrowth with abnormally thin cortices and deficiency of overlying soft tissue, distinguishing Proteus syndrome from hemihyperplasia conditions.[2][11]

CT of the craniofacial skeleton

Medical CT demonstrates the full extent of cranial hyperostosis, which consists primarily of diploic space expansion with a characteristic unilateral, parasagittal, and frontal bone distribution.[21] CT is essential for evaluating external auditory canal stenosis from hyperostosis and for assessing the relationship of cranial overgrowth to intracranial structures.[4][21]

MRI of the brain and craniofacial soft tissues

MRI identifies associated intracranial abnormalities that colocalize with overlying cranial hyperostosis, including hemimegalencephaly, polymicrogyria, periventricular heterotopias, and white matter abnormalities.[4][23] Meningiomas—the most common intracranial tumor in Proteus syndrome—colocalize with areas of cranial hyperostosis and are diagnosed at younger ages than typical sporadic meningiomas.[21] MRI also delineates soft-tissue components including lipomas, vascular malformations, and infiltrative adipose tissue in the head and neck.[2][20]

Proteus syndrome must be distinguished from other mosaic overgrowth syndromes that share features of asymmetric skeletal enlargement, vascular malformations, and soft-tissue overgrowth. The key discriminator is the disproportionate, distorting, and progressive nature of bony overgrowth in Proteus syndrome, combined with the cerebriform connective tissue nevus and postnatal onset.[8][11]

The highest-risk diagnostic pitfall is misclassifying PIK3CA-related overgrowth spectrum as Proteus syndrome, given overlapping features of asymmetric overgrowth and vascular malformations. Strict application of the consensus diagnostic criteria—requiring mosaic distribution, sporadic occurrence, progressive course, and specific clinical features—combined with molecular testing of affected tissue for the AKT1 c.49G>A variant is essential for accurate diagnosis.[8][11]

Bone

Bone histomorphometry in Proteus syndrome reveals highly increased mineralizing surface and mineral apposition rate, indicating markedly accelerated bone formation.[22] Osteoclast numbers are decreased, suggesting disturbed or delayed remodeling of primary bone.[22] The external cortex shows increased amounts of primary (woven) bone, and osteocyte lacunae are abnormally enlarged.[22] Hyperplasia of osteoid with variable calcification produces the irregular bony edges seen radiographically.[2]

Soft tissue

Resected lesions predominantly show hamartomatous mixed connective tissue overgrowth—normal tissue constituents are present but with abnormal distribution and architecture.[25] Vascular malformations, predominantly lymphatic and lymphovascular types, account for a substantial proportion of surgical specimens.[25] Lipomatous lesions range from well-circumscribed lipomas to infiltrative fatty overgrowth.[25] No malignancy or cytological atypia has been identified in resected pediatric specimens.[25]

Cerebriform connective tissue nevus

The pathognomonic cerebriform connective tissue nevus consists of highly collagenized connective tissue producing the characteristic deeply grooved, brain-like surface.[2]

Molecular correlation

The causative somatic AKT1 variant (c.49G>A, p.Glu17Lys) results in constitutive AKT phosphorylation and activation of the PI3K–AKT–mTOR pathway, driving cell proliferation and inhibiting apoptosis.[1] Variant allele fractions in affected tissues range from 1% to approximately 50%, necessitating sensitive detection methods on affected tissue rather than peripheral blood, which is uniformly negative.[1][9][18]

Diagnosis and workup

• Diagnosis follows a dyadic approach combining clinical criteria (scored ≥10 points with a confirmed AKT1 variant, or ≥15 points without) and molecular testing of affected tissue.[8][9]
• Molecular testing requires sensitive assays capable of detecting low